Lifestance Health Group stock hits 52-week low at 4.75 USD

Published 02/07/2025, 18:12
Lifestance Health Group stock hits 52-week low at 4.75 USD

Lifestance Health Group Inc (LFST) stock reached a new 52-week low, trading at 4.75 USD. According to InvestingPro data, the healthcare provider, with a market capitalization of $1.85 billion, appears undervalued at current levels. This marks a significant point for the company as it navigates the challenges of the current market environment. While the company posted strong revenue growth of 16.31% over the last twelve months, it remains unprofitable. However, analysts tracked by InvestingPro expect the company to turn profitable this year, with consensus price targets suggesting significant upside potential. The recent low highlights ongoing investor concerns and the potential for future strategic adjustments to address market conditions. For deeper insights into LFST’s valuation and growth prospects, investors can access comprehensive analysis through InvestingPro’s detailed research reports.

In other recent news, LifeStance Health Group reported its Q1 2025 earnings, marking a significant milestone with its first positive net income of $700,000. The company achieved an 11% year-over-year revenue growth, reaching $333 million, and a 25% increase in adjusted EBITDA to $35 million. UBS analyst Kevin Caliendo upgraded LifeStance Health Group’s stock rating from Neutral to Buy, setting a new price target of $8.50, citing significant growth potential. The company also announced the appointment of Vaughn Paunovich as the new Chief Technology Officer, effective June 9, 2025, to enhance its technology strategy. During its annual shareholder meeting, several key proposals were approved, including the election of board members and the ratification of PricewaterhouseCoopers LLP as the independent accounting firm. LifeStance Health Group’s strategic shift from stock-based to cash-based incentives is expected to save approximately $40 million annually in net income over four years. The company continues to focus on expanding its services, including virtual visits, which accounted for 71% of all visits.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.